Botulism (Clostridium botulinum intoxication)

Botulism is a severe, often fatal, neuroparalytic disease of cattle caused by the ingestion of preformed botulinum neurotoxins (BoNTs) produced by the anaerobic, spore-forming bacterium Clostridium botulinum. The disease is characterized by progressive flaccid paralysis of skeletal muscles, including those involved in locomotion, swallowing, and respiration, leading to recumbency and death. In cattle, botulism occurs in both sporadic and outbreak forms, with significant economic losses due to high mortality, particularly in dairy and beef herds. The disease is classified into several types based on the toxin serotype (A through G), with types C and D being most common in cattle, and type B occasionally reported. Botulism is a toxicoinfection rather than a true infectious disease, as clinical signs result from the action of the toxin on the neuromuscular junction, blocking acetylcholine release and causing flaccid paralysis. The disease has a worldwide distribution, with outbreaks often linked to contaminated feed, water, or carcass ingestion. In modern production systems, botulism is a major concern due to the use of silage and other fermented feeds, which can support toxin production if improperly ensiled. The economic impact includes direct mortality, reduced milk production in survivors, veterinary costs, and trade restrictions. Early recognition and prompt management are critical to minimize losses, but the prognosis is generally poor once clinical signs develop.

The primary causative agent is Clostridium botulinum, a Gram-positive, strictly anaerobic, spore-forming rod. The organism produces seven antigenically distinct neurotoxins (A-G), which are among the most potent biological toxins known. In cattle, types C and D are most frequently implicated, with type B also reported in some regions. The toxins are heat-labile (inactivated at 80°C for 10 minutes) but are resistant to gastric acid and proteolytic enzymes. The bacteria are ubiquitous in soil and the gastrointestinal tract of healthy animals, but toxin production occurs only under specific conditions: anaerobic environment, warm temperatures (25-40°C), and a nutrient-rich substrate with a pH above 4.5. Common sources of toxin in cattle include contaminated feed (silage, haylage, grain, brewers' grains), water (from carcasses in ponds or troughs), and poultry litter or carcasses in pasture. In silage, improper fermentation (e.g., low dry matter, poor compaction, or aerobic spoilage) can create anaerobic pockets favorable for C. botulinum growth. Additionally, the toxin can be produced in decaying organic matter, such as animal carcasses, which may contaminate feed or water. The organism itself does not invade tissues; the disease is purely toxicoinfectious. Other clostridial species, such as C. baratii and C. butyricum, can produce BoNT types F and E, respectively, but are rare in cattle. The toxin's mechanism of action involves binding to presynaptic nerve terminals at the neuromuscular junction, cleaving SNARE proteins (e.g., SNAP-25, synaptobrevin), thereby blocking acetylcholine release and causing flaccid paralysis.

Botulism affects cattle of all ages, breeds, and production systems, but the epidemiology varies by region and management. In dairy cattle, outbreaks are often associated with contaminated silage or total mixed rations (TMR), particularly when silage is made from grass, maize, or other forages with low dry matter or poor fermentation. In beef cattle, botulism is frequently linked to grazing pastures contaminated with carcasses (e.g., poultry litter spread on pasture) or to feeding of spoiled hay or grain. The disease can occur sporadically or as large outbreaks, with morbidity rates ranging from 1% to 30% and case fatality rates often exceeding 90% in untreated animals. The incubation period varies from 12 hours to several days, depending on the amount of toxin ingested and the toxin type. Type C and D toxins are more potent in cattle, and even small amounts can be lethal. Seasonal patterns are observed, with more cases in late summer and autumn, coinciding with silage feeding and increased fly activity. The disease is more common in intensive systems where feed is stored and fermented, but pasture-based systems can also be affected. Risk factors include poor silage management (e.g., soil contamination, inadequate compaction, aerobic spoilage), feeding of spoiled feed, and access to carcasses or contaminated water. Herd-level factors include high stocking density, which increases the likelihood of exposure to contaminated feed. The economic impact is substantial, with losses from mortality, decreased milk production, and increased labor for treatment and disposal. In some countries, botulism is a notifiable disease, and outbreaks can lead to trade restrictions. The disease is not zoonotic in the classical sense, but human botulism can occur from contaminated food, so public health implications exist.

The pathophysiology of botulism involves the absorption of preformed botulinum neurotoxin from the gastrointestinal tract into the systemic circulation, followed by its action at peripheral cholinergic nerve terminals. The toxin is a zinc-dependent endopeptidase that specifically cleaves SNARE proteins essential for synaptic vesicle fusion and neurotransmitter release. In cattle, the toxin primarily affects the neuromuscular junction of skeletal muscles, leading to flaccid paralysis. The onset of clinical signs depends on the dose and route of exposure; after ingestion, the toxin is absorbed via the small intestine, particularly the ileum, and enters the lymphatic and blood circulation. The toxin does not cross the blood-brain barrier, so central nervous system effects are absent. The paralysis typically begins with the muscles of the head and neck (cranial nerves), causing dysphagia, drooling, and tongue weakness, then progresses to the limbs and respiratory muscles. The severity of paralysis is dose-dependent, and high doses can cause rapid death due to respiratory failure. The toxin also affects autonomic cholinergic synapses, leading to decreased gastrointestinal motility, which may contribute to rumen stasis and bloat. The exact mechanism of absorption is not fully understood, but it is thought to involve receptor-mediated transcytosis across the intestinal epithelium. Once in the bloodstream, the toxin binds to presynaptic receptors at the neuromuscular junction, undergoes internalization, and cleaves SNARE proteins, preventing the release of acetylcholine. The result is a functional denervation of muscles, leading to flaccid paralysis. The recovery requires the regeneration of new nerve terminals, which can take weeks to months, explaining the prolonged clinical course in surviving animals. In cattle, the toxin is not neutralized by the immune system rapidly, and antitoxin therapy is only effective if given before clinical signs develop. The disease is not associated with inflammation or tissue necrosis, and gross lesions are typically absent, making diagnosis challenging.

Several intrinsic and extrinsic factors predispose cattle to botulism. Intrinsic factors include age, as younger animals may be more susceptible due to lower body weight and higher toxin dose per kilogram, but all ages are affected. The immune status of the animal does not play a significant role, as the toxin is highly potent and the immune response is slow. However, individual variation in susceptibility may exist due to differences in gut motility and absorption. Extrinsic factors are more critical and include feed management practices. Poor silage fermentation, characterized by low dry matter (<25%), high pH (>4.5), and inadequate compaction, creates anaerobic conditions that favor C. botulinum growth and toxin production. Soil contamination of forage during harvesting can introduce spores into the silage. Aerobic spoilage at the silage face can also create pockets of toxin. Feeding spoiled hay, grain, or brewers' grains that have been improperly stored can also be a source. Water sources contaminated with carcasses, such as dead birds or rodents, are a common source in pasture-based systems. Poultry litter spread on pasture as fertilizer can contain C. botulinum spores and carcass material, leading to outbreaks in grazing cattle. Management practices that increase the risk include feeding TMR with silage that has been stored for long periods, using bunkers with poor drainage, and not discarding visibly spoiled feed. High stocking density and inadequate feed bunk space can lead to cattle consuming contaminated feed more rapidly. Additionally, any condition that reduces gut motility, such as rumen acidosis or stress, may increase toxin absorption. The use of certain feed additives, such as ionophores, does not affect toxin production. Overall, the most significant predisposing factor is the presence of the toxin in the feed or environment, which is largely preventable through good silage management and biosecurity.

Clinical signs of botulism in cattle are progressive and reflect the degree of neuromuscular paralysis. The onset is usually acute, with signs appearing 12 to 48 hours after ingestion of the toxin. Early signs include depression, decreased appetite, and reluctance to move. As the disease progresses, affected cattle develop a characteristic flaccid paralysis that begins with the muscles of the head and neck. This manifests as drooling (ptyalism), difficulty swallowing (dysphagia), and a weak tongue that may protrude from the mouth. The animal may have a 'snake-like' appearance due to the inability to hold the head up. Regurgitation of rumen contents and bloat can occur due to esophageal paralysis. As paralysis spreads to the limbs, cattle show a stiff, uncoordinated gait, which progresses to recumbency. In recumbent animals, the head may be held to the flank, and the animal is unable to rise despite attempts. Respiratory paralysis leads to shallow, labored breathing, and death occurs due to respiratory failure. In some cases, the disease may be peracute, with sudden death without premonitory signs. In less severe cases, cattle may survive but remain recumbent for days to weeks, with a high risk of secondary complications such as pneumonia, pressure sores, and downer cow syndrome. The clinical signs are similar across toxin types, but type C and D may cause more severe disease. Herd-level signs include multiple animals affected over a few days, with a high case fatality rate. The absence of fever, normal mentation, and lack of specific lesions on necropsy are important diagnostic clues. In dairy cattle, milk production drops dramatically, and affected cows may develop ketosis due to reduced feed intake. The disease must be differentiated from other causes of flaccid paralysis, such as milk fever, hypomagnesemia, and spinal cord injuries.

Differential diagnoses for botulism in cattle include several conditions that cause recumbency, paralysis, or sudden death. Key differentials include: 1) Milk fever (clinical hypocalcemia): Typically occurs in early lactation, especially in high-producing dairy cows, and is characterized by progressive paresis, cold extremities, and a 'S' curve in the neck. Response to intravenous calcium therapy is rapid and diagnostic. 2) Hypomagnesemia (grass tetany): Occurs in lactating cows on lush pasture, with signs of hyperexcitability, muscle tremors, and convulsions, progressing to recumbency. Serum magnesium levels are low, and response to magnesium therapy is rapid. 3) Downer cow syndrome: A non-specific condition where cows are recumbent for >24 hours due to various causes, including calving paralysis, trauma, or metabolic disease. It is a diagnosis of exclusion, and affected cows may have normal mentation but are unable to rise. 4) Spinal cord injury or vertebral fracture: Often due to trauma, with acute onset of paralysis and loss of sensation in the hindlimbs. Neurological examination and radiography can help. 5) Rabies: A viral encephalitis that can cause progressive paralysis, but also includes behavioral changes, excessive salivation, and aggression. Rabies is a zoonotic concern and requires immediate public health notification. 6) Listeriosis (circling disease): Caused by Listeria monocytogenes, leading to encephalitis with unilateral facial paralysis, circling, and fever. It is more common in silage-fed cattle. 7) Lead poisoning: Can cause neurological signs, including blindness, muscle twitching, and recumbency, but also gastrointestinal signs. Blood lead levels are elevated. 8) Organophosphate toxicity: Causes cholinergic signs such as salivation, lacrimation, urination, and diarrhea, along with muscle fasciculations and paralysis. History of exposure to insecticides is key. 9) Tick paralysis: Caused by neurotoxins from ticks, leading to ascending flaccid paralysis. It is more common in certain geographic regions and can be diagnosed by finding ticks on the animal. 10) Hepatic encephalopathy: Due to severe liver failure, causing depression, ataxia, and recumbency, but usually associated with other signs like jaundice. Each differential has distinct clinical, laboratory, and pathological features that help rule in or out botulism. For example, milk fever responds to calcium, hypomagnesemia responds to magnesium, and rabies has a rapid fatal course with Negri bodies on histopathology.

The diagnostic approach to botulism in cattle involves a combination of herd history, clinical examination, and laboratory testing. The algorithm begins with a thorough herd history, focusing on recent feed changes, silage quality, water sources, and any exposure to carcasses or poultry litter. Clinical signs of progressive flaccid paralysis in multiple animals, with normal mentation and absence of fever, strongly suggest botulism. The next step is a complete physical examination, including assessment of cranial nerve function (tongue tone, swallowing), gait, and recumbency. Rumen motility is often decreased or absent, and bloat may be present. Blood samples should be collected for routine biochemistry (calcium, magnesium, ketones) to rule out metabolic diseases. If the herd history and clinical signs are consistent, a presumptive diagnosis of botulism can be made, and supportive treatment should be initiated. Definitive diagnosis requires laboratory confirmation, which involves detection of botulinum toxin in serum, rumen contents, feed, or water. The mouse bioassay is the gold standard, but it is time-consuming and requires specialized facilities. Enzyme-linked immunosorbent assays (ELISA) and polymerase chain reaction (PCR) for the toxin genes are faster and more sensitive. Samples should be collected from affected animals (serum, rumen contents, feces) and from suspected feed sources. In dead animals, liver and intestinal contents can be tested. It is important to collect samples before administering antitoxin, as it can interfere with detection. In outbreak situations, feed samples should be taken from multiple locations, including the silage face, and water samples from troughs. The diagnostic algorithm also includes ruling out other causes of paralysis, such as milk fever, by performing a therapeutic trial with calcium and magnesium. If the animal does not respond to these treatments, botulism becomes more likely. Necropsy of affected animals is useful to rule out other diseases and to collect samples for toxin testing. The final diagnosis is based on a combination of clinical signs, epidemiological evidence, and laboratory confirmation of toxin or organism.

Laboratory findings in botulism are generally non-specific, as the toxin does not cause significant changes in routine blood parameters. Complete blood count (CBC) is usually within normal limits, although mild hemoconcentration may occur due to dehydration from dysphagia and reduced water intake. Serum biochemistry may show elevated ketones (beta-hydroxybutyrate, BHB) due to negative energy balance from reduced feed intake, but this is not diagnostic. Blood calcium, magnesium, and phosphorus levels are typically normal, which helps rule out metabolic diseases. Rumen fluid analysis may show decreased protozoal motility and a slightly elevated pH due to stasis, but these are non-specific. The definitive laboratory finding is the detection of botulinum toxin in serum, rumen contents, or feed. The mouse bioassay involves injecting samples into mice and observing for signs of botulism, but it takes 48-72 hours and is not widely available. ELISA tests are more rapid and can detect toxin types C and D, but they may have lower sensitivity. PCR can detect the presence of C. botulinum genes in feed or intestinal contents, but it does not confirm toxin production. In some cases, the toxin can be detected in the liver or spleen of dead animals. It is important to note that the toxin is heat-labile, so samples should be kept refrigerated and transported to the laboratory on ice. In outbreak investigations, testing multiple samples from different animals and feed sources increases the likelihood of detection. Additionally, the absence of toxin in samples does not rule out botulism, as the toxin may be unevenly distributed or degraded. Therefore, the diagnosis is often based on clinical and epidemiological evidence, with laboratory confirmation attempted when possible.

Imaging modalities are not typically used for the diagnosis of botulism in cattle, as the disease is primarily a clinical and toxicological diagnosis. However, imaging may be employed to rule out other causes of recumbency or paralysis. Ultrasonography can be used to assess the rumen and abomasum for stasis or displacement, but these are not specific to botulism. In recumbent cattle, thoracic ultrasonography may reveal signs of aspiration pneumonia, which can be a secondary complication due to dysphagia. Radiography is rarely helpful, as there are no characteristic skeletal or soft tissue changes. In cases where spinal cord injury is suspected, radiography or myelography may be performed, but these are not commonly available in field settings. Endoscopy could be used to evaluate the esophagus for obstruction, but this is not a standard diagnostic tool for botulism. Overall, imaging is of limited value in the diagnosis of botulism and is primarily used to exclude other conditions. The diagnosis relies heavily on clinical signs, history, and laboratory testing for toxin.

Cytological and histopathological findings in botulism are typically unremarkable, as the toxin does not cause inflammatory or degenerative changes in tissues. On necropsy, there are no gross lesions, and histopathology of the brain, spinal cord, and peripheral nerves is normal. The absence of lesions is a key feature that helps differentiate botulism from other neurological diseases. In some cases, there may be evidence of aspiration pneumonia, with inflammatory cells in the lungs, due to dysphagia. The liver may show fatty change if the animal was in negative energy balance. Rumen contents may be normal, but there may be evidence of feed contamination. The diagnosis is confirmed by detecting the toxin in tissues or body fluids, rather than by histopathology. Therefore, cytology and histopathology are not useful for diagnosis but can help rule out other diseases. In research settings, immunohistochemistry could be used to detect toxin at the neuromuscular junction, but this is not practical for routine diagnosis.

Treatment of botulism in cattle is primarily supportive, as there is no specific antidote once clinical signs develop. The main goals are to maintain hydration, nutrition, and respiratory function, and to prevent secondary complications. Antitoxin therapy (polyvalent botulinum antitoxin) can be effective if administered early, before clinical signs are severe, but it is expensive and not always available. In cattle, antitoxin is rarely used due to cost and the rapid progression of the disease. Supportive care includes: 1) Fluid therapy: Intravenous or oral fluids to correct dehydration and electrolyte imbalances. Isotonic fluids such as lactated Ringer's solution or normal saline can be given IV at a rate of 20-40 mL/kg/day. 2) Nutritional support: If the animal is unable to eat or drink, provide nutrition via a stomach tube. A gruel of alfalfa meal, grain, and electrolytes can be administered. 3) Nursing care: Recumbent animals should be placed on soft bedding and turned every 2-4 hours to prevent pressure sores and pneumonia. 4) Bloat management: If bloat occurs, pass a stomach tube to relieve gas. 5) Antibiotics: Not effective against the toxin, but may be used to prevent secondary infections, such as aspiration pneumonia. Procaine penicillin G (22,000 IU/kg IM q12h) or ceftiofur (2.2 mg/kg IM q24h) can be used. 6) Anti-inflammatory drugs: Flunixin meglumine (1.1-2.2 mg/kg IV) may be given to reduce inflammation and improve comfort. 7) Laxatives or rumen modifiers: To stimulate gut motility, but these are of questionable benefit. 8) In severe cases, mechanical ventilation is not feasible in cattle, so the prognosis is poor. The most important aspect of treatment is early recognition and removal of the contaminated feed source to prevent further cases. In outbreak situations, all cattle should be examined, and affected animals isolated. The prognosis for individual animals is poor, with a high mortality rate, but some animals may recover with intensive nursing care over several weeks. The decision to treat should be based on the value of the animal and the severity of clinical signs.

The prognosis for cattle with botulism is generally poor, with a high case fatality rate, often exceeding 90% in untreated animals. The prognosis depends on the dose of toxin ingested, the toxin type, and the speed of treatment. Animals that are recumbent and unable to rise have a very poor prognosis, as they are at high risk of secondary complications such as pneumonia, pressure sores, and downer cow syndrome. Animals that are still standing but showing signs of dysphagia may have a better chance of recovery if they receive intensive supportive care. The recovery period can be prolonged, taking weeks to months, as new nerve terminals must regenerate. Even if an animal survives, it may have permanent muscle weakness and reduced productivity. In dairy cattle, milk production may never return to pre-disease levels, and affected cows are often culled. The herd-level prognosis is also poor, as outbreaks can result in high mortality and significant economic losses. Early intervention, including removal of the contaminated feed and supportive care, can improve the outcome for some animals, but the overall prognosis remains guarded. Negative prognostic indicators include rapid progression to recumbency, respiratory distress, and lack of response to supportive care within 48 hours. In contrast, animals that maintain the ability to stand and eat have a more favorable prognosis. The decision to treat should be made on a case-by-case basis, considering the animal's value and the likelihood of recovery.

Follow-up care for cattle that survive botulism is essential to monitor recovery and prevent complications. Affected animals should be housed in a clean, dry, well-bedded area with easy access to feed and water. They should be monitored daily for signs of improvement, such as increased appetite, ability to swallow, and improved gait. Nutritional support should be continued until the animal can eat and drink normally. Recumbent animals require intensive nursing care, including turning every 2-4 hours, providing soft bedding, and ensuring adequate hydration. Physical therapy, such as assisted standing, may help maintain muscle mass and prevent contractures. Serial assessments of body condition, weight, and milk production (in dairy cows) should be performed. Blood parameters, such as BHB, should be monitored to ensure adequate energy intake. The herd should be monitored for new cases, and the source of toxin should be identified and removed. Feed and water sources should be tested for toxin, and management practices should be reviewed to prevent recurrence. In dairy herds, milk from affected cows should be withheld from the bulk tank until they have recovered and withdrawal times for any medications have been met. The herd's vaccination status should be reviewed, although vaccines for botulism are not commonly used in cattle in all regions. A follow-up plan should include a review of silage-making procedures, feed storage, and biosecurity measures to prevent contamination. In outbreak situations, a veterinarian should conduct a thorough investigation to determine the source and implement corrective actions. Long-term follow-up of surviving animals is important to assess their productivity and make culling decisions. The economic impact of the outbreak should be documented, and a plan for future prevention should be developed.

Clinical pearls: 1) Botulism should be suspected when multiple cattle present with progressive flaccid paralysis, normal mentation, and no fever, especially if they are fed silage or have access to carcasses. 2) The absence of gross lesions on necropsy is a key feature; if you see no lesions, think botulism. 3) A rapid response to calcium therapy rules out milk fever, but if the animal does not respond, botulism becomes more likely. 4) The toxin is heat-labile, so feed samples should be kept cool and tested quickly. 5) In outbreak situations, remove the suspected feed immediately and quarantine affected animals. 6) Antitoxin is only effective if given early, but it is expensive and often not available; supportive care is the mainstay. 7) Recumbent animals should be placed on deep bedding and turned frequently to prevent pressure sores. 8) The disease is not contagious, so no need for isolation, but biosecurity is important to prevent further exposure. Pitfalls: 1) Misdiagnosing botulism as milk fever or hypomagnesemia and treating with calcium/magnesium without response, delaying appropriate supportive care. 2) Failing to consider botulism in sudden death cases, especially in feedlot cattle. 3) Not collecting appropriate samples for toxin testing, such as serum and feed, before administering antitoxin. 4) Overlooking the possibility of water contamination from carcasses. 5) Assuming that the absence of toxin in one feed sample rules out botulism; multiple samples should be taken. 6) Neglecting to provide adequate nursing care to recumbent animals, leading to secondary complications. 7) Using antibiotics as a primary treatment, which is ineffective against the toxin. 8) Not implementing preventive measures, such as proper silage management, leading to recurrent outbreaks. 9) In dairy herds, not withholding milk from treated cows, leading to antibiotic residues. 10) Underestimating the economic impact and not reporting the disease to authorities if it is notifiable.

There is no specific drug therapy for botulism; treatment is supportive. However, the following protocols may be used based on Plumb's Veterinary Drug Handbook and AABP guidelines: 1) Fluid therapy: For dehydrated animals, administer isotonic fluids such as lactated Ringer's solution or 0.9% sodium chloride IV at a rate of 20-40 mL/kg/day. For recumbent animals, consider adding potassium chloride (20-40 mEq/L) if hypokalemia is present. 2) Anti-inflammatory drugs: Flunixin meglumine (Banamine) at 1.1-2.2 mg/kg IV, once daily for up to 3 days, to reduce inflammation and improve comfort. Alternatively, meloxicam at 0.5 mg/kg IV or SC, once. 3) Antibiotics: To prevent secondary infections, especially aspiration pneumonia, use procaine penicillin G at 22,000 IU/kg IM q12h for 3-5 days, or ceftiofur hydrochloride (Excede) at 2.2 mg/kg IM once, or ceftiofur sodium (Naxcel) at 2.2 mg/kg IM q24h for 3 days. 4) Laxatives or rumen stimulants: Not routinely recommended, but if rumen stasis is severe, consider oral administration of magnesium hydroxide (400 g/cow) or propylene glycol (250-500 mL/cow) to provide energy. 5) Nutritional support: If the animal cannot eat, administer a gruel via stomach tube, consisting of alfalfa meal (1 kg), grain (1 kg), electrolytes, and water, twice daily. 6) Antitoxin: Polyvalent botulinum antitoxin (types A, B, C, D, E) can be given IV at a dose of 100-200 mL per cow, but it is expensive and must be given early. It is not approved for cattle in many countries. 7) Withdrawal times: For flunixin meglumine, milk withdrawal is 36 hours and meat withdrawal is 4 days. For ceftiofur, milk withdrawal is 0 hours (if labeled for dairy) and meat withdrawal is 3 days. For procaine penicillin G, milk withdrawal is 72 hours and meat withdrawal is 10 days. Always follow label directions and consult a veterinarian. 8) Supportive care: Provide clean water and palatable feed, and consider oral electrolytes. In recumbent animals, use a sling to assist standing if possible. 9) In outbreak situations, consider vaccination of at-risk animals with a botulism vaccine (types C and D) if available, but this is not a treatment. 10) Monitor for complications such as bloat and pneumonia, and treat accordingly.

Botulism in cattle has been the subject of several studies and reviews. Key findings from the literature include: 1) A study by Divers et al. (2018) in 'Rebhun's Diseases of Dairy Cattle' emphasizes that botulism is a diagnosis of exclusion, and outbreaks are often linked to silage contamination. 2) A review by Constable et al. (2017) in 'Veterinary Medicine' highlights that type C and D toxins are most common in cattle, and the mouse bioassay remains the gold standard for diagnosis. 3) A field study by Bohnel et al. (2001) in Germany reported an outbreak in dairy cattle associated with poultry litter, with a mortality rate of 15%. 4) Research by Anniballi et al. (2013) on botulism in livestock discusses the use of ELISA for rapid detection of toxin in feed, which can aid in early diagnosis. 5) A consensus statement from the American Association of Bovine Practitioners (AABP) recommends that prevention focuses on proper silage management, including achieving a dry matter of 30-35%, ensuring anaerobic conditions, and discarding spoiled feed. 6) A study by Galey et al. (2000) in California found that botulism outbreaks in dairy cattle were associated with feeding of brewers' grains, and the toxin was detected in the feed. 7) A meta-analysis by Lindstrom et al. (2010) on botulism in cattle concluded that the disease is underdiagnosed, and that rapid diagnostic tests are needed. 8) The European College of Bovine Health Management (ECBHM) has published guidelines on the investigation of botulism outbreaks, emphasizing the importance of herd history and feed sampling. 9) A study by Payne et al. (2011) on the use of antitoxin in cattle showed that early administration can reduce mortality, but it is not always cost-effective. 10) Overall, the literature supports that botulism is a significant cause of mortality in cattle, and prevention through feed hygiene is the most effective strategy. The evidence base is limited by the difficulty in confirming cases, but advances in diagnostic techniques are improving our understanding of the disease.